Evaluation of drugs applicable to treatment of migraine in the cranial circulation of the monkey.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002927:Cimetidine / Q000494:pharmacology; D003000:Clonidine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D004878:Ergotamine / Q000494:pharmacology; D000882:Haplorhini; D006632:Histamine / Q000494:pharmacology; D008251:Macaca; D008784:Methysergide / Q000494:pharmacology; D008785:Metiamide / Q000494:pharmacology; D008881:Migraine Disorders / Q000503:physiopathology*; D009638:Norepinephrine / Q000494:pharmacology; D010918:Pizotyline / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology
D011453:Prostaglandins; D010918:Pizotyline; D012701:Serotonin; D008785:Metiamide; D002927:Cimetidine; D006632:Histamine; D003000:Clonidine; D000109:Acetylcholine; D004878:Ergotamine; D001920:Bradykinin; D009638:Norepinephrine; D008784:Methysergide; D004837:Epinephrine